Tozkir, H.Sagiroglu, T.Kilicarslan-Ayna, T.Tan, S.Copuroglu, E.Sagiroglu, G.Sari, G.2024-06-122024-06-1220120041-1345https://doi.org/10.1016/j.transproceed.2012.05.052https://hdl.handle.net/20.500.14551/247858th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- OCT 12-16, 2011 -- Antalya, TURKEYDetermining the presence of anti-HLA antibodies before transplantation is an important factor to prevent loss of function among renal transplantations. In addition, recent studies have shown that not only the pretransplantation existence of anti-HLA antibody but also posttransplantation donor-specific antibodies (DSA) and non-donor-specific antibodies are significantly associated with allograft rejection or loss of graft function. This study presented DSA among patients after renal transplantation together with graft function and survival.en10.1016/j.transproceed.2012.05.052info:eu-repo/semantics/closedAccessAssayConference Object44616671669Q3WOS:0003074334000552-s2.0-8486441390622841240Q3